DNA Methylation, Isocitrate Dehydrogenase Mutation, and Survival in Glioma
Article Properties
-
LanguageEnglish
-
DOI (url)
-
Publication Date2011/01/19
-
Indian UGC (journal)
-
Refrences44
-
Citations189
-
Brock C. Christensen
-
Ashley A. Smith
-
Shichun Zheng
-
Devin C. Koestler
-
E. Andres Houseman
-
Carmen J. Marsit
-
Joseph L. Wiemels
-
Heather H. Nelson
-
Margaret R. Karagas
-
Margaret R. Wrensch
-
Karl T. Kelsey
-
John K. Wiencke
Cite
Christensen, Brock C., et al. “DNA Methylation, Isocitrate Dehydrogenase Mutation, and Survival in Glioma”. CancerSpectrum Knowledge Environment, vol. 103, no. 2, 2011, pp. 143-5, https://doi.org/10.1093/jnci/djq497.
Christensen, B. C., Smith, A. A., Zheng, S., Koestler, D. C., Houseman, E. A., Marsit, C. J., Wiemels, J. L., Nelson, H. H., Karagas, M. R., Wrensch, M. R., Kelsey, K. T., & Wiencke, J. K. (2011). DNA Methylation, Isocitrate Dehydrogenase Mutation, and Survival in Glioma. CancerSpectrum Knowledge Environment, 103(2), 143-153. https://doi.org/10.1093/jnci/djq497
Christensen, Brock C., Ashley A. Smith, Shichun Zheng, Devin C. Koestler, E. Andres Houseman, Carmen J. Marsit, Joseph L. Wiemels, et al. “DNA Methylation, Isocitrate Dehydrogenase Mutation, and Survival in Glioma”. CancerSpectrum Knowledge Environment 103, no. 2 (2011): 143-53. https://doi.org/10.1093/jnci/djq497.
Christensen BC, Smith AA, Zheng S, Koestler DC, Houseman EA, Marsit CJ, et al. DNA Methylation, Isocitrate Dehydrogenase Mutation, and Survival in Glioma. CancerSpectrum Knowledge Environment. 2011;103(2):143-5.
Journal Categories
Medicine
Internal medicine
Neoplasms
Tumors
Oncology
Including cancer and carcinogens
Medicine
Medicine (General)
You May Also Like
- Presalvage prostate‐specific antigen (PSA) and PSA doubling time as predictors of biochemical failure of salvage cryotherapy in patients with locally recurrent prostate cancer after radiotherapy
- A 5‐decade analysis of 13,715 carcinoid tumors
- Congestive heart failure in patients treated with doxorubicin
- PI3K/Akt signalling pathway and cancer
- Metastatic bone disease: clinical features, pathophysiology and treatment strategies
Refrences
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
| Isocitrate Dehydrogenase 1 and 2 Mutations in Cancer: Alterations at a Crossroads of Cellular Metabolism | CancerSpectrum Knowledge Environment |
| 380 | 2010 |
| Report of a phase 1/2 study of a combination of azacitidine and cytarabine in acute myelogenous leukemia and high-risk myelodysplastic syndromes | Leukemia & Lymphoma |
| 25 | 2010 |
| Regulation of the histone demethylase JMJD1A by hypoxia-inducible factor 1 alpha enhances hypoxic gene expression and tumor growth | Molecular and Cellular Biology |
| 2010 | |
| The Common Feature of Leukemia-Associated IDH1 and IDH2 Mutations Is a Neomorphic Enzyme Activity Converting α-Ketoglutarate to 2-Hydroxyglutarate | Cancer Cell |
| 1,457 | 2010 |
| IDH1 Mutations in Gliomas: When an Enzyme Loses Its Grip | Cancer Cell |
| 51 | 2010 |
Refrences Analysis
The category
Science: Biology (General): Genetics 23
is the most frequently represented among the references in this article. It primarily includes studies from Cancer Cell and New England Journal of Medicine. The chart below illustrates the number of referenced publications per year.
Refrences used by this article by year
Citations
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
IDH1 mutation inhibits differentiation of astrocytes and glioma cells with low oxoglutarate dehydrogenase expression by disturbing α-ketoglutarate-related metabolism and epigenetic modification | Life Metabolism |
| 2024 | |
| Supramaximal versus gross total resection in Glioblastoma, IDH wild-type and Astrocytoma, IDH-mutant, grade 4, effect on overall and progression free survival: systematic review and meta-analysis | Journal of Neuro-Oncology |
| 4 | 2023 |
| Cancer plasticity: Investigating the causes for this agility | Seminars in Cancer Biology |
| 9 | 2023 |
U3 snoRNA‐mediated degradation of ZBTB7A regulates aerobic glycolysis in isocitrate dehydrogenase 1 wild‐type glioblastoma cells | CNS Neuroscience & Therapeutics |
| 1 | 2023 |
Genome-Scale Methylation Analysis Identifies Immune Profiles and Age Acceleration Associations with Bladder Cancer Outcomes | Cancer Epidemiology, Biomarkers & Prevention |
| 2023 |
Citations Analysis
The category
Medicine: Medicine (General) 75
is the most commonly referenced area in studies that cite this article. The first research to cite this article was titled Detection of IDH1 Mutations and the Status of MGMT Promoter on Intraoperative Fresh Tissue Section from Frameless Neuronavigation Needle Biopsy. Analysis on 17 Patients with Brain Glial Tumor Ineligible for Craniotomy and Tumor Resection and was published in 2011. The most recent citation comes from a 2024 study titled IDH1 mutation inhibits differentiation of astrocytes and glioma cells with low oxoglutarate dehydrogenase expression by disturbing α-ketoglutarate-related metabolism and epigenetic modification. This article reached its peak citation in 2013, with 28 citations. It has been cited in 123 different journals, 20% of which are open access. Among related journals, the PLOS ONE cited this research the most, with 11 citations. The chart below illustrates the annual citation trends for this article.